top of page

Is Ranson Retiring? The Rise of BISAP

  • Writer: Eric Steinberg
    Eric Steinberg
  • May 4
  • 2 min read

Clinical Scenario

A 55-year-old man with a history of alcohol use disorder, gallstones, and hypertension arrives in the ED clutching his abdomen, describing pain that shoots straight through to his back. He’s nauseated, he’s vomited twice, and between groans, he mentions taking a thiazide diuretic - and possibly being bitten by his pet scorpion (because, of course he has one). His mental status is normal, heart rate 110, other vitals unremarkable. Lipase? 2,500. So now the question: how bad is this pancreatitis - Ranson-level serious, or just a BISAP blip?


Summary

Ranson’s: Use when serial data isare available to obtain a detailed prognosis. Best suited for guiding management decisions in the inpatient setting.


BISAP: Use at the point of care to estimate mortality risk with fewer variables than Ranson’s. Best suited for informing early disposition decisions in the ED or acute care setting.


Tool Comparison


Purpose

Predicts severity and mortality risk in acute pancreatitis, based on clinical and lab criteria over 48 hours.

Simplifies early risk stratification for acute pancreatitis using 5 easily obtained variables at bedside.

Use When...

At admission and 48 hours later — requires serial data.

At initial presentation — designed for rapid bedside assessment.

Scoring

<11 total criteria (5 at admission, 6 at 48 hrs). Higher score = increased mortality.

5 variables to be obtained within 24 hours of presentation.

Performance

Good accuracy but requires a 48-hour wait and multiple labs. Mortality rises sharply with ≥3 criteria.

Comparable prognostic accuracy to Ranson with simpler, faster assessment.

Workup

Scores 3 and above are considered “severe” and may warrant ICU admission.

Scores >0 have an increased risk of mortality, with mortality increasing significantly with a score of 3 or greater.

Common Pitfalls

• Requires several inputs.

• Delayed risk stratification.

• Not validated for all etiologies.

• Likely overestimates mortality.

• May not capture/predict delayed deterioration.

• Dependence on single-point data.


Case Resolution

In the ED, we ran the BISAP Score - quick, painless, and reassuringly low. The patient was admitted for supportive care (and, hopefully, a scorpion relocation plan). Forty-eight hours later, the inpatient team broke out the Ranson's Criteria, confirming a mild course and no major complications. A few days of fluids, pain control, and bland diet later, he was home - pancreas (and scorpion) both intact.

 
 

Don't Miss an Update!

Thanks for signing up!

Unsubscribe at any time.

  • LinkedIn
  • facebook
  • Bluesky
bottom of page